#gbsawareness

What is Guillain-Barré syndrome?

Guillain-Barré syndrome (GBS) is a rare but serious autoimmune disorder in which the body's immune system mistakenly attacks the peripheral nervous system. 

This condition is commonly triggered by infectious agents of Guillain-Barré syndrome, such as Campylobacter jejuni, Cytomegalovirus (CMV), Epstein-Barr virus (EBV), Zika virus, and COVID-19. It can also occur after vaccination or surgical procedures in rare cases. 

The immune system's attack damages the myelin sheath (the protective covering of nerves) or the axons (the nerve fibers themselves), leading to muscle weakness, numbness, and, in severe cases, paralysis. Guillain-Barré syndrome can affect people of all ages, but it is more common in adults and males. Early diagnosis and treatment are crucial to prevent complications and improve outcomes.

Guillain-Barré syndrome is considered a medical emergency because it can progress rapidly, leading to life-threatening complications such as respiratory failure. However, with prompt treatment, most patients recover fully or with minimal effects.

A neurologist is a specialist who treats Guillain-Barré syndrome (GBS). Guillain-Barré syndrome is a medical emergency that usually requires hospitalization.

Guillain-Barré syndrome meaning

The term "Guillain-Barré syndrome" is named after the French neurologists Georges Guillain and Jean Alexandre Barré, who, along with André Strohl, first described the condition in 1916. They identified the characteristic symptoms and the link between the syndrome and elevated protein levels in cerebrospinal fluid. Guillain-Barré syndrome is also known as acute inflammatory demyelinating polyneuropathy (AIDP), which refers to inflammation and damage to the myelin sheath of peripheral nerves.

Prevalence of Guillain-Barré syndrome

Incidence and prevalence of Guillain-Barré syndrome worldwide

Globally, the incidence of Guillain-Barré syndrome (GBS) is estimated to be between 1 and 2 cases per 100,000 people per year, which means it affects approximately 1-2 people out of 100,000 people each year.

Epidemiology of Guillain-Barré syndrome in Indian population

The reported incidence of Guillain-Barré syndrome in India varies, with estimates ranging from 1-2 cases per 100,000 people annually. A study conducted at major teaching hospitals found that approximately 138 cases are diagnosed each year. Another retrospective study from Rajasthan indicated a prevalence of 41.5% among cases of acute flaccid paralysis recorded between 2012 and 2015. There was a considerable male predominance (68.5%).

Symptoms of Guillain-Barré Syndrome

Have you heard about the sudden increase in Guillain-Barré Syndrome (GBS) cases? This rare neurological disorder causes muscle weakness, tingling, and imbalance as the immune system attacks the nerves.